Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Delayed Central Nervous System Irradiation Effects in Rats - Part 2: Aggravation of Experimental Autoimmune Encephalomyelitis.
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Acute transverse myelitis after thoracic epidural anesthesia and analgesia: Should anesthesia and analgesia be blamed?
High-Affinity Binding of Remyelinating Natural Autoantibodies to Myelin-Mimicking Lipid Bilayers Revealed by Nanohole Surface Plasmon Resonance.
"Disease modifying nutricals" for multiple sclerosis.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
The radiologically isolated syndrome.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
Functional MRI Examination of Visual Pathways in Patients with Unilateral Optic Neuritis.
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
Human endogenous retroviruses and the nervous system.
Genetic targeting of microglia.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
[Factorial structure of the dysexecutive questionnaire in a sample of the Spanish population with acquired brain injury and memory deficit complaints].
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Depression in multiple sclerosis: A long-term longitudinal study.
Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Pages